Literature DB >> 26597331

Evaluation of myocardial injury through serum troponin I and echocardiography in anaphylaxis.

Yong Sung Cha1, Hyun Kim2, Min Hyuk Bang1, Oh Hyun Kim1, Hyung Il Kim1, KyoungChul Cha1, Kang Hyun Lee1, Sung Oh Hwang1.   

Abstract

BACKGROUND: Anaphylaxis is an acute, lethal, multisystem syndrome that results from the sudden release of mast cell- and basophil-derived mediators. Although anaphylaxis can cause cardiac complications, the incidence of myocardial injury using troponin I (TnI) has not been characterized. In addition, patterns of cardiomyopathy have not been evaluated in patients with elevated TnI. Therefore, we studied the occurrence and patterns of myocardial injury with TnI and echocardiography in anaphylaxis.
METHODS: We conducted a retrospective review of 300 consecutive anaphylaxis cases that were diagnosed in the emergency department (ED) over 53 months (2011-2015). Myocardial injury was defined as elevation of TnI within 24hrs after arrival at the ED. We investigated systolic function and regional wall motion abnormality (RWMA) through echocardiography within 5 hours after arrival at the ED in patients with myocardial injury.
RESULTS: Among 300 patients (median age, 55 years), 22 patients demonstrated myocardial injury (7.3%). The median TnI was 0.222 ng/mL with a range from 0.057 ng/mL to 19.4 ng/mL. Three patients presented reduced systolic function and 4 patients showed RWMA. One patient showed reverse Takotsubo cardiomyopathy and other 2 patients had RWMA discordant to the distribution of coronary arteries. Another patient showed RWMA (inferior wall) with ST elevation of II, III, and aVF. All 4 patients were discharge after recovery of cardiomyopathy without any specific intervention for cardiomyopathy.
CONCLUSIONS: Myocardial injury developed in 7.3% of patients with anaphylaxis. Various cardiomyopathy, including Kounis syndrome and Takotsubo cardiomyopathy, has been observed in patients with myocardial injury.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26597331     DOI: 10.1016/j.ajem.2015.09.038

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  7 in total

1.  Kounis Syndrome Secondary to Laxative Administration.

Authors:  Mateo Zuluaga-Gómez; Daniel González-Arroyave; Carlos M Ardila
Journal:  Case Rep Med       Date:  2022-06-22

2.  Impaired Myocardial Mitochondrial Function in an Experimental Model of Anaphylactic Shock.

Authors:  Walid Oulehri; Olivier Collange; Charles Tacquard; Abdelouahab Bellou; Julien Graff; Anne-Laure Charles; Bernard Geny; Paul-Michel Mertes
Journal:  Biology (Basel)       Date:  2022-05-10

Review 3.  Anaphylactic cardiovascular collapse and Kounis syndrome: systemic vasodilation or coronary vasoconstriction?

Authors:  Nicholas G Kounis; Gianfranco Cervellin; Ioanna Koniari; Laura Bonfanti; Periklis Dousdampanis; Nikolaos Charokopos; Stelios F Assimakopoulos; Stavros K Kakkos; Ioannis G Ntouvas; George D Soufras; Ioannis Tsolakis
Journal:  Ann Transl Med       Date:  2018-09

4.  Anaphylaxis affects primarily the heart and coronary arteries: Implications of Kounis syndrome.

Authors:  Nicholas G Kounis; Ioanna Koniari
Journal:  Asia Pac Allergy       Date:  2019-04-18

5.  Kounis Syndrome Secondary to Medicine-Induced Hypersensitivity.

Authors:  Parackrama Karunathilake; Udaya Ralapanawa; Thilak Jayalath; Shamali Abeyagunawardena
Journal:  Case Rep Med       Date:  2021-10-01

Review 6.  Kounis syndrome: from an unexpected case in the Emergency Room to a review of the literature.

Authors:  Erika Poggiali; Irene Benedetti; Valeria Vertemati; Luca Rossi; Alberto Monello; Manuela Giovini; Andrea Magnacavallo; Andrea Vercelli
Journal:  Acta Biomed       Date:  2022-03-14

7.  Dimethyl Fumarate-Induced Takotsubo Cardiomyopathy in a Patient With Relapsing-Remitting Multiple Sclerosis.

Authors:  Bahadar S Srichawla
Journal:  Cureus       Date:  2022-04-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.